TY - JOUR
T1 - Measurement of Blood Pressure in Chronic Kidney Disease
T2 - Time to Change Our Clinical Practice-A Comprehensive Review
AU - Nagaraju, Shankar Prasad
AU - Shenoy, Srinivas Vinayak
AU - Rao, Indu Ramachandra
AU - Bhojaraja, Mohan V.
AU - Rangaswamy, Dharshan
AU - Prabhu, Ravindra Attur
N1 - © 2022 Nagaraju et al.
PY - 2022
Y1 - 2022
N2 - Chronic kidney disease (CKD) is extremely common all over the world and is strongly linked to cardiovascular disease (CVD). The great majority of CKD patients have hypertension, which raises the risk of cardiovascular disease (CVD), end-stage kidney disease, and mortality. Controlling hypertension in patients with CKD is critical in our clinical practice since it slows the course of the disease and lowers the risk of CVD. As a result, accurate blood pressure (BP) monitoring is crucial for CKD diagnosis and therapy. Three important guidelines on BP thresholds and targets for antihypertensive medication therapy have been published in the recent decade emphasizing the way we measure BP. For both office BP and out-of-office BP measuring techniques, their clinical importance in the management of hypertension has been well defined. Although BP measurement is widely disseminated and routinely performed in most clinical settings, it remains unstandardized, and practitioners frequently fail to follow the basic recommendations to avoid measurement errors. This may lead to misdiagnosis and wrong management of hypertension, especially in CKD patients. Here, we review presently available all BP measuring techniques and their use in clinical practice and the recommendations from various guidelines and research gaps emphasizing CKD patients.
AB - Chronic kidney disease (CKD) is extremely common all over the world and is strongly linked to cardiovascular disease (CVD). The great majority of CKD patients have hypertension, which raises the risk of cardiovascular disease (CVD), end-stage kidney disease, and mortality. Controlling hypertension in patients with CKD is critical in our clinical practice since it slows the course of the disease and lowers the risk of CVD. As a result, accurate blood pressure (BP) monitoring is crucial for CKD diagnosis and therapy. Three important guidelines on BP thresholds and targets for antihypertensive medication therapy have been published in the recent decade emphasizing the way we measure BP. For both office BP and out-of-office BP measuring techniques, their clinical importance in the management of hypertension has been well defined. Although BP measurement is widely disseminated and routinely performed in most clinical settings, it remains unstandardized, and practitioners frequently fail to follow the basic recommendations to avoid measurement errors. This may lead to misdiagnosis and wrong management of hypertension, especially in CKD patients. Here, we review presently available all BP measuring techniques and their use in clinical practice and the recommendations from various guidelines and research gaps emphasizing CKD patients.
UR - http://www.scopus.com/inward/record.url?scp=85124812143&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124812143&partnerID=8YFLogxK
U2 - 10.2147/IJNRD.S343582
DO - 10.2147/IJNRD.S343582
M3 - Review article
C2 - 35177924
AN - SCOPUS:85124812143
SN - 1178-7058
VL - 15
SP - 1
EP - 16
JO - International Journal of Nephrology and Renovascular Disease
JF - International Journal of Nephrology and Renovascular Disease
ER -